Gianni Bonadonna

Active 1968–2017

101
Papers
27,849
Citations
89
h-index
101
i10-index

Citations

Citations per year for Gianni Bonadonna1943: 1 citations1969: 2 citations1971: 5 citations1972: 3 citations1973: 4 citations1974: 11 citations1975: 18 citations1976: 15 citations1977: 30 citations1978: 18 citations1979: 21 citations1980: 20 citations1981: 26 citations1982: 52 citations1983: 51 citations1984: 34 citations1985: 59 citations1986: 46 citations1987: 54 citations1988: 51 citations1989: 75 citations1990: 83 citations1991: 96 citations1992: 110 citations1993: 102 citations1994: 129 citations1995: 128 citations1996: 106 citations1997: 119 citations1998: 147 citations1999: 135 citations2000: 168 citations2001: 178 citations2002: 182 citations2003: 232 citations2004: 210 citations2005: 248 citations2006: 192 citations2007: 184 citations2008: 186 citations2009: 156 citations2010: 149 citations2011: 137 citations2012: 126 citations2013: 99 citations2014: 94 citations2015: 104 citations2016: 74 citations2017: 76 citations2018: 63 citations2019: 246 citations2020: 237 citations2021: 236 citations2022: 121 citations2023: 74 citations2024: 142 citations2025: 44 citations2026: 2 citations1944–1968: no citations, so these years are not shown1970: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,037 citing papers, 30.5% of this breakdownItaly: 529 citing papers, 7.9% of this breakdownUnited Kingdom: 476 citing papers, 7.1% of this breakdownGermany: 358 citing papers, 5.4% of this breakdownFrance: 343 citing papers, 5.1% of this breakdownCanada: 327 citing papers, 4.9% of this breakdownChina: 299 citing papers, 4.5% of this breakdownNetherlands: 250 citing papers, 3.8% of this breakdownSwitzerland: 167 citing papers, 2.5% of this breakdownSpain: 154 citing papers, 2.3% of this breakdownAustralia: 142 citing papers, 2.1% of this breakdownBelgium: 137 citing papers, 2.1% of this breakdown
0%30.5%Other 21.8%

Fields

  • Medicine66.9%
  • Biochemistry, Genetics and Molecular Biology27.7%
  • Immunology and Microbiology1.2%
  • Materials Science0.9%
  • Mathematics0.8%
  • Pharmacology, Toxicology and Pharmaceutics0.4%
  • Other2.1%

Topics

  • Lymphoma Diagnosis and Treatment9.8%
  • Breast Cancer Treatment Studies8.8%
  • Cancer Treatment and Pharmacology4.3%
  • Breast Lesions and Carcinomas3.3%
  • CNS Lymphoma Diagnosis and Treatment3.1%
  • Viral-associated cancers and disorders2.7%
  • Other68%

Coauthors

All papers

Open in search
  1. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mitch Dowsett, Frances Duane, Vaughan Evans, Marianne Ewertz, Bernard Fisher, John Forbes, Leslie G. Ford, J.-C. Gazet, Richard D. Gelber, Lucy Gettins, Luca Gianni, Michael Gnant, Jon Godwin, Aron Goldhirsch, Pamela J. Goodwin, Richard Gray, Daniel F. Hayes, Catherine Hill, James N. Ingle, Reshma Jagsi, R. Jakesz, Sam James, Wolfgang Janni, Hui Liu, Zulian Liu, Caroline Lohrisch, Sibylle Loibl, Liz MacKinnon, Andreas Makris, Eleftherios P. Mamounas, Gurdeep Mannu, Miguel Martín, S. Mathoulin, L. Mauriac, Paul McGale, Theresa McHugh, Philip Morris, Hirofumi Mukai, Larry Norton, Yasuo Ohashi, Ivo A. Olivotto, Soon Young Paik, Hongchao Pan, Richárd Pető, Martine Piccart, Lori J. Pierce, Philip Poortmans, Trevor J. Powles, K.I. Pritchard, Joseph Ragaz, Vinod Raina, Peter M. Ravdin, Simon Read, Meredith M. Regan, J.F.R. Robertson, Emiel J. Rutgers, Suzy Scholl, Dennis J. Slamon, Lidija Sölkner, Joseph A. Sparano, Seth M. Steinberg, Rosemary Sutcliffe, Sandra M. Swain, Carolyn Taylor, Andrew Tutt, Pinuccia Valagussa, Cornelis J.�H. van de Velde, Jos A. van der Hage, Giuseppe Viale, Gϋnter von Minckwitz and 10 more - The Lancet Oncology 2017 cited by 1,133

  2. Primary Chemotherapy in Resectable Oral Cavity Squamous Cell Cancer: A Randomized Controlled Trial

    Authors: , , , , , , , , , , - Journal of Clinical Oncology 2003 cited by 315

  3. Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer

    Authors: , , , , , , , , , , - New England Journal of Medicine 1976 cited by 1,334

  4. ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned

    Authors: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2011 cited by 422

  5. Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans.

    Authors: , , , , , , , - Journal of Clinical Oncology 1995 cited by 562

  6. ABVD Plus Subtotal Nodal Versus Involved-Field Radiotherapy in Early-Stage Hodgkin's Disease: Long-Term Results

    Authors: , , , , , - Journal of Clinical Oncology 2004 cited by 337

  7. A predictive model for aggressive non-Hodgkin's lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - 1993 cited by 3,496

  8. Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP

    Authors: , , , , - Cancer 1975 cited by 760

  9. Phase III Trial Evaluating the Addition of Paclitaxel to Doxorubicin Followed by Cyclophosphamide, Methotrexate, and Fluorouracil, As Adjuvant or Primary Systemic Therapy: European Cooperative Trial in Operable Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2009 cited by 216

  10. Long-Term Cardiac Sequelae in Operable Breast Cancer Patients Given Adjuvant Chemotherapy With or Without Doxorubicin and Breast Irradiation

    Authors: , , , , , , , - Journal of Clinical Oncology 2001 cited by 186

  11. Multimodal treatment for locally advanced breast cancer. Result of chemotherapy-radiotherapy versus chemotherapy-surgery.

    Authors: , , , , , , , - 1981 cited by 155

  12. Dose-Response Effect of Adjuvant Chemotherapy in Breast Cancer

    Authors: , - New England Journal of Medicine 1981 cited by 777

  13. Phase II evaluation of adriamycin in human neoplasia

    Authors: , , , , , - Cancer 1973 cited by 417

  14. Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy.

    Authors: , , , , , , , , , - Journal of Clinical Oncology 1987 cited by 380

  15. Alternating Non-Cross-Resistant Combination Chemotherapy or MOPP in Stage IV Hodgkin's Disease

    Authors: , , - Annals of Internal Medicine 1986 cited by 365

  16. Human pharmacokinetic characterization and in vitro study of the interaction between doxorubicin and paclitaxel in patients with breast cancer.

    Authors: , , , , , , - Journal of Clinical Oncology 1997 cited by 282

  17. Clinical Evaluation of Adriamycin, a New Antitumour Antibiotic

    Authors: , , , - BMJ 1969 cited by 220

  18. Feasibility and Tolerability of Sequential Doxorubicin/Paclitaxel Followed by Cyclophosphamide, Methotrexate, and Fluorouracil and Its Effects on Tumor Response as Preoperative Therapy

    Authors: , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2005 cited by 165

  19. Role of Anthracyclines in the Treatment of Early Breast Cancer

    Authors: , , , , , - Journal of Clinical Oncology 2009 cited by 93

  20. Clinical trials with bleomycin in lymphomas and in solid tumors

    Authors: , , , , , , - European Journal of Cancer (1965) 1972 cited by 92

  21. High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma

    Authors: , , , , , , , , , , , - New England Journal of Medicine 1997 cited by 478

  22. Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD

    Authors: , , , , , - European Journal of Cancer and Clinical Oncology 1985 cited by 371

  23. 30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study

    Authors: , , , , , , - BMJ 2005 cited by 252

  24. Sequential or Alternating Doxorubicin and CMF Regimens in Breast Cancer With More Than Three Positive Nodes

    Authors: - JAMA 1995 cited by 239